The $17 million deal for the sprawling estate, which is located at 10690 Somma Way, closed on Aug. 1, according to a recent report.

No one can predict the future, but you can prepare. Find out what to prepare for and pick up the tools you’ll need at the immersive Virtual Inman Connect on Nov. 1-2, 2023. And don’t miss Inman Connect New York on Jan. 23-25, 2024, where AI, capital, and more will be center stage. Bet big on the roaring future, and join us at Connect.

A Bel-Air mansion owned by an investment group tied to a Sackler scion has sold at a $5 million loss, according to a report in The Real Deal.

The $17 million deal for the sprawling estate at 10690 Somma Way closed on Aug. 1, according to the report, with the buyer identified as an LLC linked to Emil Khodorkovsky, CEO of real estate lender Forbix Capital.

The 1987-built, two-story mansion includes a spiral staircase that leads to a spacious owner’s suite which takes up much of the second floor, and its grounds include a tennis court, pool, pavilion and covered parking for eight cars, according to the listing description on Zillow.

No real estate agents have been publicly associated with the sale on either the buyer or seller side of the high-profile transaction.


Dolcedo LLC, which Purdue heir David Sackler has a non-controlling stake in, bought the estate for $22.5 million in cash in 2018.

The Sackler family has found itself on the receiving end of unremitting backlash due to the role the family had in misleading the public and health professionals on the dangers of its drug Oxycontin.

Nearly 645,000 people lost their lives due to opioid abuse between 1999 and 2017 according to the Centers for Disease Control, a statistic that encompasses both legal substances like Oxycontin and illegal ones.

David Sackler, who sat on Purdue’s board from 2012 to 2018, testified during a heated congressional hearing in 2020 that his family was innocent of any wrongdoing.

“The family and the board acted legally and ethically,” he insisted.

Members of Congress were unconvinced, though.

“We don’t agree on a lot on this committee in a bipartisan way,” Republican James Comer said at the time. “But I think our opinion of Purdue Pharma, and the actions of your family, we all agree are sickening.”

Email Ben Verde

Show Comments Hide Comments
Sign up for Inman’s Morning Headlines
What you need to know to start your day with all the latest industry developments
By submitting your email address, you agree to receive marketing emails from Inman.
Thank you for subscribing to Morning Headlines.
Back to top
Only 3 days left to register for Inman Connect Las Vegas before prices go up! Don't miss the premier event for real estate pros.Register Now ×
Limited Time Offer: Get 1 year of Inman Select for $199SUBSCRIBE×
Log in
If you created your account with Google or Facebook
Don't have an account?
Forgot your password?
No Problem

Simply enter the email address you used to create your account and click "Reset Password". You will receive additional instructions via email.

Forgot your username? If so please contact customer support at (510) 658-9252

Password Reset Confirmation

Password Reset Instructions have been sent to

Subscribe to The Weekender
Get the week's leading headlines delivered straight to your inbox.
Top headlines from around the real estate industry. Breaking news as it happens.
15 stories covering tech, special reports, video and opinion.
Unique features from hacker profiles to portal watch and video interviews.
Unique features from hacker profiles to portal watch and video interviews.
It looks like you’re already a Select Member!
To subscribe to exclusive newsletters, visit your email preferences in the account settings.
Up-to-the-minute news and interviews in your inbox, ticket discounts for Inman events and more
1-Step CheckoutPay with a credit card
By continuing, you agree to Inman’s Terms of Use and Privacy Policy.

You will be charged . Your subscription will automatically renew for on . For more details on our payment terms and how to cancel, click here.

Interested in a group subscription?
Finish setting up your subscription